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Summary
Recent technological des elopmenis tn radiation oncolog . enabled
by high—speed computers. are allowing better target Iocahiation.
faster throughput and more con fined treatment delivery. Although
available in only certain locations and benePcial for only selected
cases, lntensit \lodulated Radiation Therap\ I MRT) and Stereo—
tactic Radiosuruer (SRS represent exciting and revolutionar
techniques of providine more concise doses of radiation to spccifi
callv tarceted olmies while minimizing radiation to surrounding
non-target tlssues IMRT and SRS. thereflwe. theoreticall\ can
improve control rates while loss crineto\icli\ of radiation treatnient.
While the iechnoio is less expensive and less logtsticall\ chal
lenging than machines for neutron and proton delivery, increased
time fortreatment planning and quality assurance, financial feasibil
ity and cost-effectiveness remain significant issues and have there
fore limited more widespread application. Research continues on
the ise of chemotherapy and biologic modifiers to alter cell sensi—
ti it\ to radiation, decrease side effects, and i ntpros e the therapeutic
ratio. Potential applications are e’panding for use otbrachtherap\
to present restenosis and in the treatment of brain, breast, and
prostate tieoplasms. but are prescml liriuted b\ lack of nature
studies and reimbursement issues. Due to the high costs of radio
therapy technology acquisition and equipment maintenance, in
creasing stall salaries and teltuous reimbursement environment,
care should be taken to avoid unnecessary duplication of services in
the community
Historical Perspective
Technological hrcakthrouehs are al loss ui5’ or more selectu se ‘Se
delis cry. Hist ricallv and for most cases toda\
- radiation heatii are
used to treat patients from fixed angles throuch a sin Ic platic called
a coplanartechnique. Atother times. treatment is delivered with the
head ot the I lilac rotating around the patic in in arcs or using a non—
coplanar techinque with the table and machine gantry angled such
that oblique beams enter the patient from different planes. The
combination of multiple beams entering the patient from different
angles provides higher doses of radiation to the target volume at the
intersection of the beams relatis e to the surrounding tissues through
hich the hcanis enterand exit the iticni. An analog5 of this ss ould
he several spotlights pointed at a stace actoi pertorning in a
darkened auditorium. The tareem volume. iii this case the actor.
ould be bathed in a hieher intcnsim.v of light relative to othet
locations in the surrounding auditorium.
1 raditionalls. beams pioducerl b\ tile linac’s are luwe or rectan
gular iii shape with I meld sites as determined h the treating phssi—
cian. The site of the field is designed to include the taigem volume
plus a margin to account for the infiltratise naiute of malignant
neoplasms in general. as ss eli as, the ph sical drop-oft in dose at the
edges of the field, patient and organ motion. Shaped fields are
created by using thick. heavy metal alloy cerrohend blocks with
delivery of fairly even doses of radiation across the volume at given
depths. The rise of shaped combinatu ns of fields is called 3—I)
conformal therapy and is presently available at all radiation facilities
ti [lass au. 4lultmleaf collimators are tiosv replaciite cerrobend
blocking in many centers. \lultileafcoilnnators rise tutnltiple. small
i3 to It> miii. blocking Icas esorse mcnts that can he nios cdiii from
the mare ins o 1 the lie Id t replic aic shaped cerrobend fields. Two
mator ads antaee of niulnlcal collimation are that the radiatmon
therapist doesn’t need to I ih heavy cerrohend blocks, some of which
weigh up to 40 pounds. and the ahiliD to perform IMRT.
Intensity Modulated Radiation Therapy (IMRT)
‘The adveiit of high—speed computers and multileaf coil i nation has
allowed for even more complex treatment planning and for tilodu
lation of segments svithmn the radiation beam by selectu vels blocking’
and unblockin port!ons of the tield dnruiig treatment tisitig coplanar
fixed beams or rotational arcs. [sing conthitiations of segmetited
heanis entering the target from different directions. i’adiation plans
can be generated to delis cr extremely selectis e and heterogeneous
intensit\ modulated radiation dose distributions within a target
volume. Hence, instead of a homogeitous, even dose distribution
across the target volume. I MRT allows selective targeting to areas
of sped lie concern with less radiation to normal adjacent tissues.
Care must still he taken not to exceed radiation dose tolerance of
critical organs. Sitice these orc’ans can he partiallm shielded with
INIRT. the total dose to the gt’oss tunmor s olume can iii some cases
he safeR escalated. Thus, tumor control mates ma be improved.
while side effects of miormal orvaui tadmation mas he loss ered.
Indications for the use of IMRT are e\pandine ss miii current
projections to include roughly I 5( of all patients umidergoing
radiation treatment, At tile present time. IMRT is commonly being
used in Hawaii to treat cancers in the prostate, head and neck, Key
concerns am’ising with INIRT are the potential for local recurrence
and recnrremices at the edee of the radiation field due to organ motion
and underestitllationi of extent of ins olvemnent. PrevioLisl\. sinttl
tioti ton radiation treatment piannitig’ ss as done on m,hc treatnncnt
mnachinue ‘rssith tiuoroseopv Huts to anamomiiicailv idetitmtv tareet
volunics a defined h\ pmetrcatmtient radiographic iumiaging svitli
respect to their reiatm’ml i skeletal and sit tissue lamldnmarks. The
advent of computed tomography >CT planning alloss s the ability to
image tile patient in the treattisent position for more acctIrate
identification of target and critical organ olumes, Various external
devices c.an he r.i.ed frsr patient m.mohi.l..iiation a.nd better reprod.uc
ihility of patient set up: however, internal organ motion remains an
issue.
Sftssare amid lechmi’loe\ hetne pr’senil\ intn’dtmced into the
marketplace and shsscaed at national mneetimigs alloss’ for fusion
and mleanl\ smnimiltaneus data aequi’mtion of CT with miiagnctie
resomiance imagine \lRl and postFofl emitissiomi touiloi’rapli\ PEL
scans to alios ton esen mime se iecimse tareeting of raliammomm dose
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within a specified volume. t et to be answered is the question 01
whether more js better. or w ill the coinhination oh technologies onls
result in inure shades of gray (no pun intended \ew technology
also exists to account for internal organ motion with respiratory
gatinP. ultrasound and CT verification of positioning. In the case of
respirator\ eating. the beam can he switched oIl when the target
move moses away from the beam. or in the case of the Cvher Kni Ic.
the treatment head can be mos ed in relation to the Isocenter.
L:ltrinnd and CT nnaeinc equipment stationed in the treatment
ault can be nsed to adiust treatment set up relatis e to the target
solunie. Limited practical applications and tinancial teasihility
remain significant impediments to widespread acquisition of these
technologies.
Brachytherapy
\d\ anlaccs of ning high—dose rate HDR brachvtherapv include
decreased os erahl patient treannent times and less exposure 01
radi4 itherapy and hospital stall, HDR prostate brachytherapy has the
theoretical advantage over permanent seeds of better radiation dose
tailoring, hut requires patient hospitalization as the treatment is
generally fractionated over t\s o days, Research continues on the use
I breast and hi-am balloon iinplaitts. —\t ilii’ time. lack of mature
dat a. onee rtts ‘eva ‘dine adcq nate d we di st ri but ion, and reimburse
iflCitt issues limit application. lntras asenlar therap Gr
l’c’ettionoIernar artery restenosis i5 being done n the comnin—
nit\ hut may he replaced by drug coated stents if reimbursement
issues can he addressed,
Stereotactic Radiosurgery (SRS)
The combination ol. multiple small caliber beams or arcs allows
delivery of hich doses small less than 3 cm diameter tarvet
volumes with dramatic dose tall ott’. such that ‘nri’onndine tmscne
are mmimallv radiated. The treatments termed SR S when gis en as
a single fraction or stereotactie radiotherapy tSRT when fraction
ated over a period of time. SRS and SRT can he done with special
modifications to the linac or with dedicated units, such as the
Gamma Knife. The Gamma Knife is limited to intracranial applica
tions. but has the potemttial advantage of deli sering more heteroge
neous dose distributions, which tend to be centi-al lv hotter where
cancer cells tend to be less oxygenated, more necrotic and less
radiorespon si se. \\ i th proper un tin mhi hitat ion and localization tech —
nology. linac—based stereotactic radiosurgcr
has both intra- and extracranial potential appli
cation. But as most extracranial tumors gener
ally invols e larger vol Limes. SRS and SRT are
generall reserved for primary brain neoplasms
and certain functional disorders. The role of
SRS in the treatment of brain metastases is not
well defined, and treatment criteria arc evolv—
ing. There is a growing database supporting its
use instead of or in combination with whole
brain radiation, Overall patient prognosis. per
formance status, number of brain lesions, and
extent of s stemic ins oh ement arc important
considerations since SRS aiid SR ‘F’ are costl\
Radiosensitizers and
Radioprotectants
The list of chemotherap agents to sensitize
cancer cells t radiation continues to grow, and
like much of medicine in the post Human Ge-
tome Protect era will increasingl\ head toward
the molecular lcsel with agents that are more
selectivel targeted. Research continues on
appi cation 01 age as m protect mt unial tissues
from the ettect of’radiation. Alihouch promis
inc. et’ficaer is variable and treatments are cx
pensive. Co.st, iogst1cal ist..ues and sid.e effects
re•ma.in significant harriers to wi.de.spread appli
cation.
There is a time
life when we start
to understand
what really
matters.
Helping people with
terminal illness, their
families and loved
ones live every day at
924-9255
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